492 related articles for article (PubMed ID: 24462903)
1. Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease.
Overk CR; Masliah E
Biochem Pharmacol; 2014 Apr; 88(4):508-16. PubMed ID: 24462903
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
[TBL] [Abstract][Full Text] [Related]
3. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.
Hashimoto M; Masliah E
Neurochem Res; 2003 Nov; 28(11):1743-56. PubMed ID: 14584828
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein in Lewy body disease and Alzheimer's disease.
Hashimoto M; Masliah E
Brain Pathol; 1999 Oct; 9(4):707-20. PubMed ID: 10517509
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.
Trudler D; Sanz-Blasco S; Eisele YS; Ghatak S; Bodhinathan K; Akhtar MW; Lynch WP; Piña-Crespo JC; Talantova M; Kelly JW; Lipton SA
J Neurosci; 2021 Mar; 41(10):2264-2273. PubMed ID: 33483428
[TBL] [Abstract][Full Text] [Related]
6. Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies.
Klucken J; McLean PJ; Gomez-Tortosa E; Ingelsson M; Hyman BT
Neurochem Res; 2003 Nov; 28(11):1683-91. PubMed ID: 14584822
[TBL] [Abstract][Full Text] [Related]
7. Neuropathological and Biomarker Findings in Parkinson's Disease and Alzheimer's Disease: From Protein Aggregates to Synaptic Dysfunction.
Compta Y; Revesz T
J Parkinsons Dis; 2021; 11(1):107-121. PubMed ID: 33325398
[TBL] [Abstract][Full Text] [Related]
8. Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer's and Parkinson's Disease.
Gutierrez BA; Limon A
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885050
[TBL] [Abstract][Full Text] [Related]
9. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of synuclein aggregation in Lewy body disease.
Mukaetova-Ladinska EB; McKeith IG
Mech Ageing Dev; 2006 Feb; 127(2):188-202. PubMed ID: 16297436
[TBL] [Abstract][Full Text] [Related]
13. Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and dementia with Lewy bodies.
Frigerio I; Bouwman MMA; Noordermeer RTGMM; Podobnik E; Popovic M; Timmermans E; Rozemuller AJM; van de Berg WDJ; Jonkman LE
Acta Neuropathol Commun; 2024 Jan; 12(1):4. PubMed ID: 38173031
[TBL] [Abstract][Full Text] [Related]
14. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
Cong C; Zhang W; Qian X; Qiu W; Ma C
J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
[TBL] [Abstract][Full Text] [Related]
15. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
[TBL] [Abstract][Full Text] [Related]
16. The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer's Disease.
Yin X; Qiu Y; Zhao C; Zhou Z; Bao J; Qian W
Med Sci Monit; 2021 Sep; 27():e933084. PubMed ID: 34471085
[TBL] [Abstract][Full Text] [Related]
17. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.
Schulz-Schaeffer WJ
Acta Neuropathol; 2010 Aug; 120(2):131-43. PubMed ID: 20563819
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.
Muntané G; Dalfó E; Martinez A; Ferrer I
Neuroscience; 2008 Apr; 152(4):913-23. PubMed ID: 18343584
[TBL] [Abstract][Full Text] [Related]
19. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
Iwai A
Biochim Biophys Acta; 2000 Jul; 1502(1):95-109. PubMed ID: 10899435
[TBL] [Abstract][Full Text] [Related]
20. Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease.
Pickett EK; Rose J; McCrory C; McKenzie CA; King D; Smith C; Gillingwater TH; Henstridge CM; Spires-Jones TL
Acta Neuropathol; 2018 Nov; 136(5):747-757. PubMed ID: 30191401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
